Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1β

Kidney International

Volumn 69, Issue 2, 2006, Pages 272-280

  Yung, S ^a   Tsang, R C W ^a   Leung, J K H ^a   Chan, T M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anti DNA antibodies; Human mesangial cells; Hyaluronan; IL 1b

Indexed keywords

DNA ANTIBODY; HYALURONIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PROTEIN INHIBITOR; SYNTHETASE; TRITIUM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY ISOLATION; ANTIBODY TITER; ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE ACTIVITY; ENZYME INDUCTION; FEMALE; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; ISOTOPE LABELING; KIDNEY BIOPSY; KIDNEY TUBULE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE MIGRATION; MALE; MESANGIUM; MESANGIUM CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; REMISSION; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ADULT; ANTIBODIES, ANTINUCLEAR; CELLS, CULTURED; FEMALE; GLOMERULAR MESANGIUM; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; INTERLEUKIN-1; LUPUS NEPHRITIS; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 33644661974     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000042     Document Type: Article

References (52)

1. Tan EM. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 1982; 33: 167-240.
2. Chan TM, Leung JKH, Ho KN, Yung S. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. J Am Soc Nephrol 2000; 13: 1219-1229.
3. Winfield JB, Faiferman I, Koffler D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. J Clin Invest 1997; 59: 90-96.
4. Termaat RM, Assmann KJM, von Son JPHF et al. Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes. Lab Invest 1993; 68: 164-173.
5. DeGrendele H, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997; 278: 672-675.
6. Clark R, Wikner N, Doherty D, Norris D. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. J Biol Chem 1988; 263: 12115-12123.
7. Laskin DL, Soltys RA, Berg RA, Riley DA. Activation of alveolar macrophages by native and synthetic collagen-like peptides. Am J Respir Cell Biol 1994; 10: 58-64.
8. McKee CM, Penno MB, Cowman M et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996; 98: 2403-2413.
9. Sampson PM, Rochester CL, Freundlich B, Elias JA. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J Clin Invest 1992; 90: 1492-1503.
10. Laurent TC, Fraser RE. Hyaluronan. FASEB J 1992; 6: 2397-2404.
11. Oksala O, Salo T, Tammi R et al. Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem 1995; 43: 125-135.
12. Underhill CB, Nguyen HA, Shizari M, Cutly M. CD44 positive macrophages take up hyaluronan during lung development. Dev Biol 1993; 155: 324-336.
13. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumour development. J Exp Med 1994; 180: 53-66.
14. Lewington AJ, Padanilam BJ, Martin DR, Hammeramn MR. Expression of CD44 in kidney after acute ischemic injury in rats. Am J Physiol 2000; 278: R247-R254.
15. Wells F, Larsson E, Tengblad A et al. The localization of hyaluronan in normal and rejected human kidneys. Transplantation 1990; 50: 240-243.
16. Nishikawa K, Andres G, Bhan AK et al. Hyaluronate is a component of crescents in rat autoimmune glomerulonephritis. Lab Invest 1993; 68: 146-153.
17. Sibalic V, Fan X, Loffing J, Wüthrich RP. Upregulated renal tubular CD44, hyaluronan and osteopontin in kdkd mice with interstitial nephritis. Nephrol Dial Transplant 1997; 12: 1344-1353.
18. lpr kidney: role of cytokines. Nephron 1999; 83: 66-73.
19. Yung S, Coles GA, Davies M. IL-1β, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney Int 1996; 50: 1337-1343.
20. Jones S, Jones S, Phillips AO. Regulation of renal proximal tubular epithelial cell hyaluronan generation: implication for diabetic nephropathy. Kidney Int 2001; 59: 1739-1749.
21. Wilkinson TS, Potter-Perigo S, Tsoi C et al. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am J Respir Cell Mol Biol 2004; 31: 92-99.
22. Lemay S, Mao C, Singh AK. Cytokine gene expression in the MRL/lpr model of lupus nephritis. Kidney Int 1996; 50: 85-93.
23. MacPhee PJ. Estimating rat renal medullary interstitial oncotic pressures and the driving force for fluid uptake into ascending vasa recta. J Physiol (London) 1998; 506: 529-538.
24. Ginetzinsky AG. Role of hyaluronidase in the reabsorption of water in renal tubules: the mechanism of action of antidiuretic hormone. Nature 1958; 182: 1218-1219.
25. Turney JH, Davison AM, Forbes MA, Cooper EH. Hyaluronic acid in end-stage renal failure treated by haemodialysis: clinical correlates and implications. Nephrol Dial Transplant 1991; 6: 566-570.
26. Hällgren R, Engstrom-Laurent A, Nisbeth U. Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue uremia. Nephron 1987; 46: 150-154.
27. Johnsson C, Tufveson G, Wahlberg J, Hällgren R. Experimentally- induced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney. Kidney Int 1996; 50: 1224-1229.
28. Hällgren R, Gerdin B, Tufveson G. Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. Relationship to the transplantation edema. J Exp Med 1990; 171: 2063-2096.
29. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4: 528-539.
30. Beck-Schimmer B, Oertli B, Pasch T, Wüthrich RP. Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J Am Soc Nephrol 1998; 9: 2283-2290.
31. Oertli B, Beck-Schimmer B, Fan X, Wüthrich RP. Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-κB and activating protein-1. J Immunol 1998; 161: 3431-3437.
32. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 1993; 14: 111-115.
33. Levesque MC, Haynes BF. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-γ. J Immunol 2001; 166: 188-196.
34. Nakamura K, Yokohama S, Yoneda M et al. High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice. J Gastroenterol 2004; 39: 346-354.
35. Wang A, Hascall VC. Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. J Biol Chem 2004; 279: 10279-10285.
36. Faaber P, Capel PJ, Rijke GP et al. Cross-reactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol 1984; 55: 502-508.
37. Kashihara N, Hirakawa S, Mino Y et al. A study on cross-reactivity of anti-DNA antibody with glycosaminoglycans. Acta Med Okayama 1993; 47: 255-259.
38. Prehm P. Synovial hyaluronate in rheumatoid arthritis binds C1q and is covalently bound to antibodies: a model for chronicity. Ann Rheum Dis 1995; 54: 408-412.
39. Itano N, Sawai T, Yoshida M et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999; 274: 25085-25092.
40. Devey ME, Lee SR, Le Page S et al. Serial studies of the IgG subclass and functional affinity of DNA antibodies in systemic lupus erythematosus. J Autoimmun 1988; 1: 483-494.
41. Biji M, Dijstelbloem HM, Oost WW et al. IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus. Rheumatology 2000; 41: 62-67.
42. Göransson V, Johnsson C, Jacobson A et al. Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemia-reperfusion injury in the rat. Nephrol Dial Transplant 2004; 19: 823-830.
43. Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002; 277: 41046-41059.
44. Wight TN, Kinsella MG, Qwarnstrom EE. The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol 1992; 4: 793-801.
45. West DC, Kumar S. Hyaluronan and angiogenesis. Ciba Found Symp 1989; 143: 187-201.
46. Li Y, Rahmanian M, Widstrom C et al. Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression. Am J Respir Cell Mol Biol 2000; 23: 411-418.
47. Ito T, Williams JD, Fraser D, Phillips AO. Hyaluronan attenuates transforming growth factor-β1 -mediated signaling in renal proximal tubular epithelial cells. Am J Pathol 2004; 164: 1979-1988.
48. Bombardier C, Gladman DD, Urowitz MB et al. Derivative of the SLEDAI. A disease activity index for lupus patients. The Committee of prognosis Studies in SLE. Arthritis Rheum 1992; 53: 630-640.
49. Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int 2000; 58: 1953-1962.
50. Peters H, Border WA, Rückert M et al. -Arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis. Kidney Int 2003; 63: 1382-1392.
51. Yung S, Woods A, Chan TM et al. Syndecan-4 up-regulation in proliferative renal disease is related to microfilament organization. FASEB J 2001 published online 10.1096/fj.00-0794fje.
52. Yung S, Coles GA, Williams JD, Davies M. The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 1994; 46: 527-533.